Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

153 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tumor-derived IL-6 may contribute to the immunological defect in CLL.
Buggins AG, Patten PE, Richards J, Thomas NS, Mufti GJ, Devereux S. Buggins AG, et al. Among authors: devereux s. Leukemia. 2008 May;22(5):1084-7. doi: 10.1038/sj.leu.2405015. Epub 2007 Nov 1. Leukemia. 2008. PMID: 17972945 No abstract available.
Somatic CLL mutations occur at multiple distinct hematopoietic maturation stages: documentation and cautionary note regarding cell fraction purity.
Marsilio S, Khiabanian H, Fabbri G, Vergani S, Scuoppo C, Montserrat E, Shpall EJ, Hadigol M, Marin P, Rai KR, Rabadan R, Devereux S, Pasqualucci L, Chiorazzi N. Marsilio S, et al. Among authors: devereux s. Leukemia. 2018 Apr;32(4):1041-1044. doi: 10.1038/leu.2017.343. Epub 2017 Dec 5. Leukemia. 2018. PMID: 29203856 Free PMC article. No abstract available.
CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.
Majid A, Lin TT, Best G, Fishlock K, Hewamana S, Pratt G, Yallop D, Buggins AG, Wagner S, Kennedy BJ, Miall F, Hills R, Devereux S, Oscier DG, Dyer MJ, Fegan C, Pepper C. Majid A, et al. Among authors: devereux s. Leuk Res. 2011 Jun;35(6):750-6. doi: 10.1016/j.leukres.2010.10.022. Epub 2010 Nov 18. Leuk Res. 2011. PMID: 21093051
153 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page